Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis Meeting Abstract

  

Authors:	Choueiri, T. K.; Figueroa, D. J.; Liu, Y.; Gagnon, R. C.; Deen, K. C.; Carpenter, C.; Bartlett-Pandite, A. N.; De Souza, P.; Powles, T.; Motzer, R. J.
Abstract Title:	Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis
Meeting Title:	2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	4 Suppl.
Meeting Dates:	2014 Jan 30-Feb 1
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-02-01
Language:	English
ACCESSION:	WOS:000335318100414
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.4_suppl.416
Notes:	Meeting Abstract: 416 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/52467